James Demetriades Named CEO of Penn Medicine Princeton Health
The University of Pennsylvania Health System has named James Demetriades as CEO of Penn Medicine Princeton Health. Demetriades has been with Penn Medicine Princeton Health for 17 years, and currently serves as Senior Vice President and Chief Operating Officer. He has been a key player in some of Princeton Health’s most important milestones over the past several years – a transformative time that included joining the University of Pennsylvania Health System. Demetriades succeeds Barry Rabner, who has served as President and CEO since 2002.
“James is a proven leader who we are excited to elevate into a role in which he will help chart and execute Penn Medicine Princeton Health’s journey forward as an institution that sets the highest standards in care for patients and the community in New Jersey,” said University of Pennsylvania Health System CEO Kevin B. Mahoney.
Demetriades led the overall system planning and execution process to become part of the University of Pennsylvania Health System, collaborating with other senior leaders to execute the Medical Staff Development Plan and serving as the management liaison to the Princeton Health Board of Trustees’ Strategic Planning Committee that developed a five-year strategic plan for 2020-2025. In addition to his ongoing responsibilities for clinical departments and ancillary and support services, he also provides leadership for emergency management at Princeton Health, including the comprehensive work done throughout the COVID-19 pandemic.
“I am honored to be given the opportunity to serve Penn Medicine Princeton Health as the CEO. I have spent 17 years here because I believe it is an outstanding organization and I hope to provide the kind of strategic leadership that will continue to propel us forward,” Demetriades said. “I am grateful to have a team of very knowledgeable and caring colleagues, the guidance of a highly committed board and the strength of the entire Penn Medicine system supporting our work.”